Skip to main content
. Author manuscript; available in PMC: 2024 Jul 30.
Published in final edited form as: J Thromb Thrombolysis. 2021 Apr;51(3):675–681. doi: 10.1007/s11239-020-02221-5

Fig. 1.

Fig. 1

Serum biomarkers of platelet reactivity at baseline and risk of the composite endpoint of cardiovascular death, myocardial infarction, or ischemic stroke through long-term follow-up. Kaplan–Meier event rates are reported through 30 months (i.e., 18 months post-randomization). KM Kaplan–Meier, MRP myeloid-related protein, sCD40L soluble CD40 ligand, T tertile